Royal UNIBREW A/S
Share buy-back program
Share buy-back program
COMPANY ANNOUNCEMENT NO 36/2025 - JULY 7, 2025
On February 25, 2025, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 3/2025 of February 25, 2025.
The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse, as amended (the Market Abuse Regulation - MAR) and the Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016.
The share buy-back program is expected to be realized in the period from February 26, 2025, to August 15, 2025. The total transaction value of the share buy-backs in the period will not exceed DKK 250m.
The following transactions on Nasdaq Copenhagen A/S have been made under the program:
| Number of Shares | Average purchase price DKK | Transaction value, DKK | |
| Accumulated, last announcement | 361,575 | 538.77 | 194,806,123 |
| June 30, 2025 | 9,732 | 515.90 | 5.020.781 |
| July 1, 2025 | 7,817 | 521.96 | 4.080.186 |
| July 2, 2025 | 5,000 | 527.61 | 2.638.038 |
| July 3, 2025 | 5,000 | 526.82 | 2.634.092 |
| July 4, 2025 | 4,000 | 530.61 | 2.122.446 |
| Total accumulated under the program | 393,124 | 537.49 | 211,301,666 |
With the transactions stated above Royal Unibrew owns a total of 526,446 shares, corresponding to 1% of the share capital. The total amount of shares in the company is 50,200,000, including treasury shares.
For further information please contact:
Flemming Ole Nielsen (Head of Investor Relations)
E-mail: Flemming.Nielsen@royalunibrew.com
Telephone: +45 25 41 68 04
Encl.
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Hvidbjerg Bank A/S7.7.2025 13:09:56 CEST | Pressemeddelelse
Hvidbjerg Bank A/S opjusterer forventningerne til resultatet før skat for 2025
Boehringer Ingelheim Limited7.7.2025 13:00:09 CEST | Press release
Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema
CGTN7.7.2025 12:47:25 CEST | Press release
CGTN: How is Greater BRICS empowering the Global South?
Yacht Club de Monaco7.7.2025 12:33:31 CEST | Press release
At the Yacht Club de Monaco, a discussion on alternative fuels for the future of the maritime sector
Vaisala Group7.7.2025 12:00:00 CEST | Press release
Vaisala's Half Year Financial Report January–June 2025 to be published on July 25, 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom